Rp Management, LLC Biocryst Pharmaceuticals Inc Transaction History
Rp Management, LLC
- $19.5 Million
- Q1 2024
A detailed history of Rp Management, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Rp Management, LLC holds 3,846,154 shares of BCRX stock, worth $25.1 Million. This represents 99.98% of its overall portfolio holdings.
Number of Shares
3,846,154
Previous 3,846,154
-0.0%
Holding current value
$25.1 Million
Previous $23 Million
15.19%
% of portfolio
99.98%
Previous 99.99%
Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
256Shares Held
182MCall Options Held
839KPut Options Held
816K-
Black Rock Inc. New York, NY18.4MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.7MShares$115 Million0.0% of portfolio
-
State Street Corp Boston, MA17.5MShares$114 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY13.1MShares$85.1 Million0.8% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$66 Million0.65% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.21B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...